Navigation Links
Pramlintide in Medical News

Use of Mealtime Pramlintide Added to Basal Insulin Showed Similar Improvements in Glycemic Control Compared to Rapid-Acting Insulin, With Lower Risk of Hypoglycemia and Without Weight Gain: Data Presented at ADA 2009

Additional Analyses Showed Pramlintide Improved Treatment Satisfaction and Quality of Life NEW ORLEANS, June 6 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN ) today announced data showing that the use of mealtime SYMLIN(R) (pramlintide acetate) injection improved gluc...

Amylin Pharmaceuticals to Present Compelling Efficacy and Safety Data From Diabetes Programs at ADA 2009

...:30 PM ET). Poster: "Clinical and Patient Reported Outcomes in Adults with Type 2 Diabetes on Basal Insulin Randomized to Addition of Mealtime pramlintide or Rapid-Acting Insulin" will be presented by Mark Peyrot, Ph.D. during a poster session on Saturday, June 6 from 11:30 AM - 1:30 PM CT (12:30 - 2:30 ...

Pipeline for New Obesity Therapies is Focus of New Report

...ide; Amylin/Lilly), exenatide LAR (Lilly/Amylin/Alkermes), exenatide + recombinant leptin (r-metHuLeptin; Amylin/Amgen), Symlin (pramlintide; Amylin), pramlintide + AC162352 (PYY 3-36; Amylin), liraglutide (NN2211; Novo Nordisk), albiglutide (GSK / Human Genome Science), PC-DAC:Exendin-4 (ConjuChem), Boc5 (SH-78...

Endocrinology Panel Examines Interplay Between Diabetes and Cardiovascular Disease in New Report

...his report: metformin, Januvia/Janumet (sitagliptin; Merck), Byetta (exenatide; Lilly/Amylin), exenatide LAR (Lilly/Amylin/Alkermes), Symlin (Amylin), pramlintide + leptin (Amylin/Amgen), Galvus (vildagliptin; Novartis), alogliptin (Takeda), saxagliptin (BMS/AZ), Redona (denagliptin; GSK), liraglutide (Novo Nord...

GlycoMark Blood Test Included in Global Diabetes Care Guidelines as Emerging Technology

...ion and other meetings show that GlycoMark is particularly valuable in detecting underlying treatment effects of agents such as exenatide (Byetta) and pramlintide (Symlin) which were not revealed by the gold standard hemoglobin A1C test. These findings have important implications for patient care and pharmaceuti...

Pramlintide-A Boon to Restrain Fast Food Consumption

...g and the desire to eat high-fat foods and sweets. pramlintide is the synthetic form of amylin, a satiety hormone...the pancreas, which also produce insulin. pramlintide treatment reduces 24-hour caloric intake and meal ... partnership with insulin to regulate blood sugar. pramlintide is also under development as a potential drug for ...
Pramlintide in Medical Technology

Amylin Pharmaceuticals to Present Novel Data on Promising Obesity Pipeline at 2008 Annual Scientific Meeting of The Obesity Society

...45 p.m. ET). 3. Poster 323-P: "Safety of 360 ug pramlintide BID treatment for up to 2 years" will be pres...g scale scores in obese subjects treated with pramlintide as monotherapy and in combination with oral w...ut Pramlintide/Metreleptin Combination Treatment pramlintide acetate is a synthetic analog of the natural hormo...

DURABLE Clinical Trial Results Show GlycoMark is Key Test for Managing Patients with Diabetes

... Additional Studies Indicate GlycoMark May Be a More Effective Monitor Than Hemoglobin A1C of Exenatide, Sitagliptin, pramlintide and Prandial Insulin Therapies in Certain Diabetic Populations SAN FRANCISCO, June 7 /PRNewswire/ -- GlycoMark, Inc. announced today r...

Amylin Pharmaceuticals Initiates Phase 2B Dose-Ranging Clinical Study of Pramlintide/Metreleptin Combination Treatment in Obesity

...st that metreleptin may be an effective partner to pramlintide in the treatment of obesity. The full paper, pub... to the development of obesity treatments. About pramlintide and Metreleptin pramlintide is a synthetic analog of amylin, a neurohormone se...

Amylin Pharmaceuticals to Present New Data from Broad Diabetes and Obesity Programs at ADA 2007

...e presented by Jonathan Roth, Ph.D. on Monday, June 25 at 3:45 PM CT (4:45 PM ET). 6. Oral: "Sustained Weight Loss Following 1-y pramlintide Treatment as an Adjunct to Lifestyle Intervention in Obesity" will be presented by Steven Smith, M.D. on Monday, June 25 at 5:30 PM CT...
Pramlintide in Biological News

FDA Approves New Drug to Treat Type I and Type II Diabetes

...es. Symlin should not be used if patients cannot tell when their blood sugar is low, have gastroparesis (slow stomach emptying), or are allergic to pramlintide acetate, metacresol, D-mannitol, acetic acid, or sodium acetate. Side effects associated with Symlin include but are not limited to nausea, vomitin...
Pramlintide in Biological Technology

Amylin Pharmaceuticals Announces Positive Results from Dose-Ranging Clinical Study of Pramlintide/Metreleptin Combination Treatment for Obesity

...eptin was more than additive compared to that with pramlintide and metreleptin alone, a finding that was not obse...g eight treatment regimens: 1) placebo/placebo; 2) pramlintide 360 mcg/placebo; 3) metreleptin 5 mg/placebo; 4) pramlintide 180 mcg/metreleptin 2.5 mg; 5)...

Amylin Pharmaceuticals Reports Third Quarter Financial Results

...kground of metformin therapy. Obesity Program -- Completed enrollment of a phase 2B study to evaluate different dosing combinations of pramlintide and metreleptin. The objective of this dose-ranging study is to support dose selection for phase 3, and to guide the development of a deliv...

Amylin Pharmaceuticals to Present Promising Data From Diabetes and Obesity Programs at ADA 2008

... a poster session on Monday, June 9 from 12:00 - 2:00 PM PT (3:00 - 5:00 PM ET). 2. Oral: "Enhanced Weight Loss Following Co-Administration of pramlintide with Sibutramine or Phentermine in Obese Subjects" will be presented by Louis Aronne, M.D. on Saturday, June 7 at 5:00 PM PT (8:00 PM ET). ...

Study Supports Use of GlycoMark Blood Test to Evaluate Therapy in Children with Diabetes

...ion and other meetings show that GlycoMark is particularly valuable in detecting underlying treatment effects of agents such as exenatide (Byetta) and pramlintide (Symlin) which were not revealed by the gold standard hemoglobin A1C test. These findings have important implications for patient care and pharmaceuti...
Other Tags
(Date:8/31/2015)... ... September 01, 2015 , ... ... back pain – once required a long, arduous recovery. However, today’s minimally invasive ... pain, less blood loss and minimal muscle damage. These advantages of minimally invasive ...
(Date:8/31/2015)... ... August 31, 2015 , ... ... at Western University of Health Sciences to learn more about its integrated approach ... of Dental Sciences and Institute of Cellular Medicine at Newcastle University, and Susan ...
(Date:8/31/2015)... , ... August 31, 2015 , ... ... recently opened registration for the company’s second Introduction to Hyperbaric Medicine Course. The ... 15-18, 2015 aboard the Queen Mary Hotel in Long Beach, CA. The meeting ...
(Date:8/31/2015)... , ... August 31, 2015 , ... ... Vice President, Marketing and Corporate Communications. In this capacity, Michael will provide strategic ... is an industry leader in consumer-focused programs that have contributed to the company’s ...
(Date:8/31/2015)... Angeles, CA (PRWEB) , ... August 31, 2015 , ... ... journal article from the Plastic and Reconstructive Surgery Global Open Journal that discusses the ... general. The article discussed how, in the future, customized implants, prosthetics, and other 3-D ...
Breaking Medicine News(10 mins):Health News:Minimally Invasive Spinal Fusions Squash Back Pain without Arduous Recovery 2Health News:Minimally Invasive Spinal Fusions Squash Back Pain without Arduous Recovery 3Health News:Minimally Invasive Spinal Fusions Squash Back Pain without Arduous Recovery 4Health News:Western Diabetes Institute Collaborates with UK team 2Health News:Western Diabetes Institute Collaborates with UK team 3Health News:Western Diabetes Institute Collaborates with UK team 4Health News:Registration Opens for Wound Care Advantage’s Second UHMS Approved 40-Hour Introduction to Hyperbaric Medicine Course 2Health News:Registration Opens for Wound Care Advantage’s Second UHMS Approved 40-Hour Introduction to Hyperbaric Medicine Course 3Health News:Registration Opens for Wound Care Advantage’s Second UHMS Approved 40-Hour Introduction to Hyperbaric Medicine Course 4Health News:CareSource Names Vice President, Marketing and Corporate Communications 2Health News:Recent Article on 3-D Printing Highlights the Future of Custom Medical Solutions Using the Technology, says Beverly Hills Physicians 2Health News:Recent Article on 3-D Printing Highlights the Future of Custom Medical Solutions Using the Technology, says Beverly Hills Physicians 3
(Date:8/5/2015)... VIEW, Calif. , Aug. 5, 2015 ... exhibits continuous growth in applications, penetration into newer sectors, ... after year. The global biosensors space has seen the ... exited the market so far. (Photo - ... Frost & Sullivan, Analysis of the Global Biosensors ...
(Date:8/4/2015)...  AMRI (NASDAQ: AMRI ) today reported financial and operating ... Highlights: , Second quarter contract revenue of $ ... , Adjusted contract margins of 26 % ... $0.05 decrease in EPS from royalties in the current quarter ... "We are very pleased to present another strong financial quarter, ...
(Date:7/31/2015)... SHENZHEN , Kina, 31. juli 2015 ... ) bliver afholdt af BGI fra den 22. - 25. ... Konferencen fejrer sin 10-års fødselsdag i år. ... verdens mest indflydelsesrige årlige møder på ,omik,-feltet, og er ... forsamlinger. ICG-10 fokuserer på nylige gennembrud ...
Breaking Biology News(10 mins):Innovative Biosensors Incite Use in Non-Traditional Applications 2Innovative Biosensors Incite Use in Non-Traditional Applications 3Innovative Biosensors Incite Use in Non-Traditional Applications 4AMRI Announces Second Quarter 2015 Results 2AMRI Announces Second Quarter 2015 Results 3AMRI Announces Second Quarter 2015 Results 4AMRI Announces Second Quarter 2015 Results 5AMRI Announces Second Quarter 2015 Results 6AMRI Announces Second Quarter 2015 Results 7AMRI Announces Second Quarter 2015 Results 8AMRI Announces Second Quarter 2015 Results 9AMRI Announces Second Quarter 2015 Results 10AMRI Announces Second Quarter 2015 Results 11AMRI Announces Second Quarter 2015 Results 12AMRI Announces Second Quarter 2015 Results 13AMRI Announces Second Quarter 2015 Results 14AMRI Announces Second Quarter 2015 Results 15AMRI Announces Second Quarter 2015 Results 16AMRI Announces Second Quarter 2015 Results 17AMRI Announces Second Quarter 2015 Results 18AMRI Announces Second Quarter 2015 Results 19AMRI Announces Second Quarter 2015 Results 20AMRI Announces Second Quarter 2015 Results 21AMRI Announces Second Quarter 2015 Results 22AMRI Announces Second Quarter 2015 Results 23AMRI Announces Second Quarter 2015 Results 24Den 10. internationale konference om Genomics (ICG-10) åbner i oktober 2
Other Contents